Open Interest and Volume Dynamics
On 27 Mar 2026, Fortis Healthcare’s open interest (OI) in derivatives rose sharply to 29,421 contracts from 24,929 the previous session, marking an increase of 4,492 contracts or 18.02%. This notable rise in OI was accompanied by a futures volume of 8,355 contracts, reflecting active trading interest. The futures value stood at ₹41,245.08 lakhs, while the options segment exhibited a substantial notional value of ₹1,253.63 crores, culminating in a total derivatives value of approximately ₹41,447.26 lakhs.
The underlying stock price closed at ₹813, having touched an intraday low of ₹811.05, down 2.29% on the day. This decline contrasts with the sector’s 1.49% fall and the Sensex’s 1.51% drop, indicating Fortis underperformed its peers marginally by 0.41%.
Price Trend and Moving Averages
Fortis Healthcare’s price action reveals a bearish undertone. The stock has reversed after two consecutive days of gains, closing lower by 1.86% on the day. It is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling sustained downward momentum. This technical positioning suggests that short-term and long-term investors remain cautious, with resistance levels likely to cap any immediate upside.
Investor Participation and Liquidity
Investor participation appears to be waning, as evidenced by a 12.14% decline in delivery volume to 11.64 lakh shares on 25 Mar compared to the 5-day average. This drop in delivery volume indicates reduced conviction among long-term holders or institutional investors. However, liquidity remains adequate for sizeable trades, with the stock’s average traded value supporting a trade size of approximately ₹3.41 crores based on 2% of the 5-day average.
Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.
- - Strong fundamental track record
- - Consistent growth trajectory
- - Reliable price strength
Market Positioning and Potential Directional Bets
The surge in open interest amid falling prices suggests that market participants are actively repositioning. An increase in OI typically indicates fresh money entering the market, which can be interpreted as either new bullish bets or fresh shorts. Given Fortis Healthcare’s recent price weakness and its downgrade from a Hold to a Sell rating on 6 Mar 2026, the latter scenario appears more plausible.
Traders may be increasing short positions in the futures and options markets, anticipating further downside. The substantial options notional value exceeding ₹1,253 crores points to significant hedging or speculative activity, possibly through put options or bear spreads. This aligns with the stock’s underperformance relative to the hospital sector and the broader market.
Mojo Score and Analyst Sentiment
Fortis Healthcare currently holds a Mojo Score of 30.0, categorised as a Sell, reflecting deteriorated fundamentals and technicals. This is a downgrade from its previous Hold rating, signalling increased caution among analysts. The mid-cap hospital stock’s market capitalisation stands at ₹61,464.92 crores, placing it in a competitive segment where sector peers may offer better risk-reward profiles.
Comparative Sector and Market Context
Within the hospital sector, Fortis Healthcare’s relative underperformance and negative momentum contrast with some peers that have maintained steadier price trends. The sector’s 1.49% decline on the day was less severe than Fortis’s 1.86% drop, underscoring the stock’s vulnerability. The broader Sensex also declined by 1.51%, reflecting a generally cautious market environment.
Is Fortis Healthcare Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Implications for Investors
Investors should approach Fortis Healthcare with caution given the current technical and fundamental signals. The sharp rise in open interest amid falling prices and reduced delivery volumes suggests that bearish sentiment is gaining traction. The downgrade to a Sell rating and the stock’s position below all major moving averages reinforce the risk of further downside.
Those holding long positions may consider tightening stops or reducing exposure, while traders looking for opportunities might explore short-term bearish strategies in the derivatives market. Conversely, value investors should await clearer signs of a trend reversal and improved fundamentals before committing fresh capital.
Outlook and Conclusion
Fortis Healthcare’s recent derivatives activity highlights a market grappling with uncertainty and shifting sentiment. The 18% increase in open interest, combined with declining prices and investor participation, points to a cautious outlook. While the hospital sector remains vital, Fortis’s current positioning and rating downgrade suggest it is not favoured among market participants at this juncture.
Monitoring open interest trends alongside price action will be crucial in the coming sessions to gauge whether the stock stabilises or continues its downward trajectory. For now, the evidence leans towards a bearish stance, with investors advised to prioritise risk management and consider alternative opportunities within the healthcare space.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
